Inverness Counsel LLC Brooklyn Immuno Therapeutics, Inc. Transaction History

Inverness Counsel LLC

$1.8 Billion
Q3 2022

A detailed history of Inverness Counsel LLC transactions in Brooklyn Immuno Therapeutics, Inc. stock. As of the latest transaction made, Inverness Counsel LLC holds 1,210,537 shares of BTX stock, worth $0. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,210,537

Previous 1,210,537 -0.0%

Holding current value

Previous $627,000 52.31%

% of portfolio

0.02%

Previous 0.04%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	BUY	$4.17 - $9.79 $4.99 Million - $11.7 Million	1,196,915 Added 8786.63%	1,210,537 $5.05 Million
Q3 2021 Nov 02, 2021	BUY	$8.86 - $17.05 $2,790 - $5,370	315 Added 2.37%	13,622 $127,000
Q2 2021 Aug 10, 2021	BUY	$3.75 - $78.5 $49,901 - $1.04 Million	13,307 New	13,307 $240,000

Others Institutions Holding BTX

# of Institutions

Shares Held

1.21M

Call Options Held

Put Options Held

View Full List

About Brooklyn ImmunoTherapeutics, Inc.

Ticker BTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,825,700
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...

More about BTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inverness Counsel LLC , based on Form 13F filings with the SEC.

News

Stay updated on Inverness Counsel LLC with notifications on news.

Account

Inverness Counsel LLC Brooklyn Immuno Therapeutics, Inc. Transaction History